Literature DB >> 20544796

alpha4 phosphoprotein interacts with EDD E3 ubiquitin ligase and poly(A)-binding protein.

William J McDonald1, Shirley M Sangster, Lori D Moffat, Michelle J Henderson, Catherine K L Too.   

Abstract

Mammalian alpha4 phosphoprotein, the homolog of yeast Tap42, is a component of the mammalian target-of-rapamycin (mTOR) pathway that regulates ribogenesis, the initiation of translation, and cell-cycle progression. alpha4 is known to interact with the catalytic subunit of protein phosphatase 2A (PP2Ac) and to regulate PP2A activity. Using alpha4 as bait in yeast two-hybrid screening of a human K562 erythroleukemia cDNA library, EDD (E3 isolated by differential display) E3 ubiquitin ligase was identified as a new protein partner of alpha4. EDD is the mammalian ortholog of Drosophila hyperplastic discs gene (hyd) that controls cell proliferation during development. The EDD protein contains a PABC domain that is present in poly(A)-binding protein (PABP), suggesting that PABP may also interact with alpha4. PABP recruits translation factors to the poly(A)-tails of mRNAs. In the present study, immunoprecipitation/immunoblotting (IP/IB) analyses showed a physical interaction between alpha4 and EDD in rat Nb2 T-lymphoma and human MCF-7 breast cancer cell lines. alpha4 also interacted with PABP in Nb2, MCF-7 and the human Jurkat T-leukemic and K562 myeloma cell lines. COS-1 cells, transfected with Flag-tagged-pSG5-EDD, gave a (Flag)-EDD-alpha4 immunocomplex. Furthermore, deletion mutants of alpha4 were constructed to determine the binding site for EDD. IP/IB analysis showed that EDD bound to the C-terminal region of alpha4, independent of the alpha4-PP2Ac binding site. Therefore, in addition to PP2Ac, alpha4 interacts with EDD and PABP, suggesting its involvement in multiple steps in the mTOR pathway that leads to translation initiation and cell-cycle progression. Published 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20544796     DOI: 10.1002/jcb.22624

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

1.  Protein phosphatase 2A (PP2A)-specific ubiquitin ligase MID1 is a sequence-dependent regulator of translation efficiency controlling 3-phosphoinositide-dependent protein kinase-1 (PDPK-1).

Authors:  Beatriz Aranda-Orgillés; Désirée Rutschow; Raphael Zeller; Antonios I Karagiannidis; Andrea Köhler; Changwei Chen; Timothy Wilson; Sven Krause; Stefan Roepcke; David Lilley; Rainer Schneider; Susann Schweiger
Journal:  J Biol Chem       Date:  2011-09-19       Impact factor: 5.157

2.  Quantitative proteomics reveals novel protein interaction partners of PP2A catalytic subunit in pancreatic β-cells.

Authors:  Xiangmin Zhang; Divyasri Damacharla; Danjun Ma; Yue Qi; Rebecca Tagett; Sorin Draghici; Anjaneyulu Kowluru; Zhengping Yi
Journal:  Mol Cell Endocrinol       Date:  2016-01-09       Impact factor: 4.102

Review 3.  Serine-threonine protein phosphatases: Lost in translation.

Authors:  Victoria Kolupaeva
Journal:  Biochim Biophys Acta Mol Cell Res       Date:  2018-08-20       Impact factor: 4.739

4.  Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

Authors:  Tyler M MacDonald; Lynn N Thomas; Emily Daze; Paola Marignani; Penelope J Barnes; Catherine Kl Too
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

5.  EDD inhibits ATM-mediated phosphorylation of p53.

Authors:  Shiyun Ling; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

6.  Identification and characterization of an alternatively spliced isoform of the human protein phosphatase 2Aα catalytic subunit.

Authors:  Deivid L S Migueleti; Juliana H C Smetana; Hugo F Nunes; Jörg Kobarg; Nilson I T Zanchin
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

7.  The putative RNA helicase HELZ promotes cell proliferation, translation initiation and ribosomal protein S6 phosphorylation.

Authors:  Philippe A Hasgall; David Hoogewijs; Marius B Faza; Vikram G Panse; Roland H Wenger; Gieri Camenisch
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

8.  UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.

Authors:  Kumar Saurabh; Parag P Shah; Mark A Doll; Leah J Siskind; Levi J Beverly
Journal:  BMC Cancer       Date:  2020-08-31       Impact factor: 4.430

9.  UBR5 oncogene as an indicator of poor prognosis in gastric cancer.

Authors:  Fanghui Ding; Xiaoliang Zhu; Xiaojing Song; Pei Yuan; Longfei Ren; Changpeng Chai; Wence Zhou; Xun Li
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.